标题 |
First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations
naporafenib(LXH254)联合或不联合spartalizumab治疗MAPK信号通路改变的晚期实体瘤成人患者的首次人体研究
|
网址 | |
DOI | |
求助人 | |
下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |